Ramy Tadros Metlife Inc (MET) insider trading activity

Ramy Tadros is President, U.S. Business of METLIFE INC. Currently has a direct ownership of 146,981 shares of MET, which is worth approximately $12 Million. The most recent transaction as insider was on Mar 13, 2024, when has been sold 4,026 shares (Common Stock) at a price of $71.9 per share, resulting in proceeds of $289,469. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 147K

0% 3M change

26.52% 12M change

Total Value Held $12 Million

RAMY TADROS Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 13 2024	SELL Open market or private sale	$289,469 $71.9 p/Share	4,026 Reduced 2.67%	146,981 Common Stock
Mar 01 2024	SELL Payment of exercise price or tax liability	$336,168 $69.73 p/Share	4,821 Reduced 3.09%	151,007 Common Stock
Feb 27 2024	SELL Payment of exercise price or tax liability	$2,257,105 $69.16 p/Share	32,636 Reduced 17.32%	155,828 Common Stock
Feb 27 2024	BUY Grant, award, or other acquisition	-	72,294 Added 27.72%	188,464 Common Stock
Aug 31 2023	BUY Grant, award, or other acquisition	-	7,894 Added 6.36%	116,170 Common Stock
Mar 01 2023	SELL Payment of exercise price or tax liability	$355,138 $71.27 p/Share	4,983 Reduced 4.4%	108,276 Common Stock
Feb 28 2023	SELL Payment of exercise price or tax liability	$2,586,798 $71.73 p/Share	36,063 Reduced 24.15%	113,259 Common Stock
Feb 28 2023	BUY Grant, award, or other acquisition	-	77,560 Added 34.19%	149,322 Common Stock
Mar 01 2022	SELL Payment of exercise price or tax liability	$300,806 $64.44 p/Share	4,668 Reduced 6.11%	71,762 Common Stock
Feb 22 2022	SELL Payment of exercise price or tax liability	$1,539,325 $68.96 p/Share	22,322 Reduced 22.6%	76,430 Common Stock
Feb 22 2022	BUY Grant, award, or other acquisition	-	52,733 Added 34.81%	98,752 Common Stock
Mar 02 2021	SELL Payment of exercise price or tax liability	$14,917 $58.96 p/Share	253 Reduced 0.55%	46,019 Common Stock
Mar 01 2021	SELL Payment of exercise price or tax liability	$122,565 $59.44 p/Share	2,062 Reduced 4.27%	46,272 Common Stock
Feb 23 2021	SELL Payment of exercise price or tax liability	$223,977 $57.43 p/Share	3,900 Reduced 7.47%	48,334 Common Stock
Feb 23 2021	BUY Grant, award, or other acquisition	-	19,369 Added 27.05%	52,234 Common Stock
Sep 11 2020	SELL Payment of exercise price or tax liability	$699,456 $38.23 p/Share	18,296 Reduced 50.04%	18,267 Common Stock
Sep 11 2020	BUY Exercise of conversion of derivative security	-	34,377 Added 48.46%	36,563 Common Stock
Mar 02 2020	SELL Payment of exercise price or tax liability	$49,417 $44.56 p/Share	1,109 Reduced 33.66%	2,186 Common Stock
Mar 02 2020	BUY Exercise of conversion of derivative security	-	2,899 Added 48.8%	3,042 Common Stock
Mar 04 2019	SELL Payment of exercise price or tax liability	$12,008 $45.66 p/Share	263 Reduced 39.91%	396 Common Stock
Mar 04 2019	BUY Exercise of conversion of derivative security	-	659 Added 50.0%	659 Common Stock

Ramy Tadros

President, U.S. Business

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MET shares.

Notify only if

Value

Insider Trading

Get notified when an Metlife Inc insider buys or sells MET shares.

Notify only if

Operation

Value

Type

News

Receive news related to METLIFE INC

Track Activities on MET

Account